University of Edinburgh at ESMO 2026
Oct 23–27, 2026 Madrid, Spain ~37k attendees Website
University of Edinburgh takes part in 3 sessions at ESMO 2026 in Madrid. Its sessions span cancer diagnostics, health economics and the challenges of putting digital health into practice. It presents international validation of a liquid biopsy platform for early brain tumour detection, and a trial-based cost analysis of gene assay-guided chemotherapy in high-risk early breast cancer.
| Organization | ESMO 2026 Attendance |
|---|---|
University of Edinburgh Edinburgh, United Kingdom | |
Public research university in Edinburgh, Scotland, with a medical school and cancer research institute. | Abstract Fri Oct 23 13:40–13:45 697RO - The international validation of a liquid biopsy platform for the early detection of brain tumours Sarcoma, CNS, head & neck and rare cancers Abstract Sun Oct 25 11:13–11:33 Talk Mon Oct 26 11:15–11:35 |
Instantly find 20 buyers from University of Edinburgh
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction